Bernd Hoppe Selected Research

Nephrocalcinosis

7/2022	Improving Treatment Options for Primary Hyperoxaluria.
4/2022	Diet-related urine collections: assistance in categorization of hyperoxaluria.
2/2022	Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry.
1/2021	Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
1/2020	Plasma oxalate levels in primary hyperoxaluria type I show significant intra-individual variation and do not correlate with kidney function.
1/2020	Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.
1/2020	Inherited conditions resulting in nephrolithiasis.
12/2019	Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up.
12/2018	Novel therapeutic approaches in primary hyperoxaluria.
3/2017	Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernd Hoppe Research Topics

Disease

31	Hyperoxaluria (Oxaluria) 04/2022 - 09/2003
27	Primary Hyperoxaluria (Oxaluria, Primary) 07/2022 - 09/2003
21	Nephrocalcinosis 07/2022 - 09/2003
18	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 05/2009
15	Urolithiasis 07/2022 - 09/2003
13	Renal Insufficiency (Renal Failure) 02/2022 - 04/2009
9	Chronic Renal Insufficiency 12/2019 - 04/2006
8	Kidney Calculi (Kidney Stone) 02/2022 - 11/2011
8	Primary hyperoxaluria type 1 02/2022 - 05/2009
6	Atypical Hemolytic Uremic Syndrome 06/2015 - 02/2005
4	Hereditary Nephritis (Alport Syndrome) 01/2021 - 03/2012
4	Hypercalciuria 01/2020 - 04/2002
4	Disease Progression 01/2020 - 12/2008
4	Kidney Diseases (Kidney Disease) 01/2019 - 09/2005
4	Inflammation (Inflammations) 01/2019 - 01/2016
3	Inborn Genetic Diseases (Disease, Hereditary) 04/2021 - 11/2011
3	Rare Diseases (Rare Disease) 01/2020 - 01/2007
3	Proteinuria 01/2017 - 03/2012
3	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2015 - 05/2005
3	Thrombotic Microangiopathies 06/2015 - 02/2005
3	Nephrolithiasis 10/2014 - 01/2009
3	Calculi (Calculus) 01/2013 - 01/2010
3	Dent Disease 01/2009 - 02/2005
2	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 09/2018 - 07/2008
2	Body Weight (Weight, Body) 01/2018 - 09/2014
2	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 12/2015 - 02/2015
2	Juvenile gout 05/2010 - 01/2009
2	Cystic Kidney Diseases (Cystic Kidney Disease) 05/2010 - 01/2009
2	Infections 01/2010 - 09/2004
2	Poisoning 04/2009 - 12/2008
2	Acidosis 07/2008 - 04/2006
2	Complement Factor H Deficiency 01/2007 - 02/2005
2	Oculocerebrorenal Syndrome (Lowe Syndrome) 12/2006 - 02/2005
1	Water Intoxication 07/2022
1	Infantile Nephropathic Cystinosis 01/2022
1	Albuminuria 01/2020
1	Primary hyperoxaluria type 2 12/2019
1	Papilledema 10/2019
1	Fibrosis (Cirrhosis) 10/2019
1	Congenital Abnormalities (Deformity) 01/2019
1	Hypertrophy 01/2019
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2019
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2019
1	Muscular Diseases (Myopathy) 01/2019
1	Cystinosis 01/2019
1	Hypoxia (Hypoxemia) 07/2018

Drug/Important Bio-Agent (IBA)

37	OxalatesIBA 07/2022 - 09/2003
14	Calcium OxalateIBA 04/2022 - 05/2005
13	CalciumIBA 01/2019 - 09/2003
12	glyoxylic acid (glyoxylate)IBA 07/2022 - 06/2009
7	Citric Acid (Citrate)FDA LinkGeneric 07/2022 - 12/2008
7	EnzymesIBA 02/2022 - 07/2008
6	Phosphates (Orthophosphate)IBA 01/2019 - 04/2006
6	Proteins (Proteins, Gene)FDA Link 10/2015 - 06/2006
5	Complement System Proteins (Complement)IBA 09/2014 - 02/2005
4	Retinaldehyde (Retinal)IBA 01/2022 - 06/2006
4	Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA 01/2018 - 09/2010
4	Complement Factor H (Factor H)IBA 11/2009 - 02/2005
3	Vitamin B 6IBA 07/2022 - 03/2014
2	Cystine (L-Cystine)IBA 01/2022 - 01/2019
2	Cysteamine (Mercaptamine)FDA Link 01/2022 - 01/2019
2	hydroxide ionIBA 01/2019 - 10/2014
2	Parathyroid Hormone (Parathormone)IBA 01/2019 - 07/2017
2	InflammasomesIBA 01/2019 - 12/2018
2	Vitamin D FDA LinkGeneric 01/2019 - 10/2014
2	GlutaratesIBA 01/2018 - 12/2017
2	eculizumab FDA Link 10/2015 - 06/2015
2	CreatinineIBA 10/2015 - 09/2014
2	MagnesiumIBA 01/2013 - 06/2012
2	UromodulinIBA 05/2010 - 01/2009
2	Ethylene Glycol (Monoethylene Glycol)IBA 04/2009 - 12/2008
2	Protons (Proton)IBA 01/2009 - 12/2006
2	AntiportersIBA 01/2009 - 12/2006
2	ChloridesIBA 01/2009 - 12/2006
2	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2006 - 02/2005
2	Chloride Channels (Chloride Channel)IBA 12/2006 - 02/2005
1	nedosiranIBA 01/2022
1	Lactate Dehydrogenase 5IBA 04/2021
1	stiripentolIBA 01/2021
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2020
1	Vitamin D3 24-HydroxylaseIBA 01/2020
1	Calcium-Sensing ReceptorsIBA 01/2020
1	Ramipril (Altace)FDA LinkGeneric 01/2020
1	Therapeutic UsesIBA 01/2020
1	calcium phosphateIBA 01/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Testosterone (Sustanon)FDA Link 01/2019
1	VitaminsIBA 01/2019
1	ElectrolytesIBA 01/2019
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 01/2019
1	Thyroid HormonesIBA 01/2019

Therapy/Procedure

20	Kidney Transplantation 02/2022 - 10/2003
16	Therapeutics 01/2022 - 02/2005
6	Transplantation 02/2022 - 05/2009
3	Liver Transplantation 12/2019 - 05/2009
3	Renal Dialysis (Hemodialysis) 06/2017 - 12/2008
1	Conservative Treatment 01/2020
1	Extracorporeal Membrane Oxygenation 07/2018